apparently, flossing your teeth helps, too.
“the bacteria that grow in your gums accumulate bio germs and flossing your teeth once a day decreases the bacterial load and helps protect the brain,” chertkow said.
new and expensive
there is a drug on the market called lecanemab. the canadian drug agency (cda) rejected it initially “because their analysis suggested the benefit simply wasn’t strong enough to bring it into the country,” chertkow said.
it works by targeting and clearing toxic clumps of amyloid-beta proteins in the brain, thereby reducing cognitive decline and allowing patients to maintain independence for a longer period.
it was approved last october by the cda. it is expensive, about $40,000-$50,000 for a 12- to 18-month treatment. currently, the drug is not covered in ontario by ohip.
“when it is given to people who have mild alzheimer’s, they don’t get better and return to being normal, they don’t stabilize and stop progressing, but they progress more slowly, maybe 30% more slowly,” chertkow said. “it is not nothing, but it is not a cure.”
coming down the pipe
last week, at the alzheimer’s association international conference in london, topics on the docket included new insights into alzheimer’s blood tests for improving diagnosis in primary care and for predicting future cognitive decline.
and much more, the doctor said.
“there are a lot of things coming down the pipe,” chertkow said. “some are at the earliest stages and some more advanced. medication against brain inflammation and prevention strategies against inflammation is another big area. other things being pursued, in which we don’t have the final results. there was talk about viagra and cialis and these drugs appear to have a benefit for the brain, as well. they appear to be protective and prevent alzheimer’s and degenerative diseases.”